Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Could metals help treat cancer?

28.07.2008
A fruitful collaboration between chemists and biologists has made it
possible to identify the effects of a new class of molecules,
polyoxometalates(1), primarily composed of metals and oxygen.
These molecules are very powerful inhibitors of a specific protein kinase,
CK2, an enzyme that is overactive in a number of cancers. The enzyme's
instrumental role in controlling cell proliferation and survival makes
it an important target in the search for new medications.
These results have just been published in the journal Chemistry and Biology by
chemists from the Institut de chimie moléculaire (CNRS / UPMC) and
biologists from the Institut de recherche en technologies et sciences
pour le vivant (iRTSV, CEA de Grenoble / CNRS / Inserm).
*Phosphorylation enzymes (2), which include the protein kinase CK2, play
a critical role in controlling cell proliferation. Deregulated protein
kinase activity is implicated in a number of cancers, which has led to a
recent surge in research on molecules that can inhibit the activity of
these enzymes. The currently known CK2 inhibitors are all organic
compounds that neutralize enzymatic activity by binding to its active
site (3).
The contribution of the study carried out by the researchers at the
Institut de chimie moléculaire and the Institut de recherche en
technologies et sciences pour le vivant was to reveal a new class of CK2
inhibitors. The new inhibitors are inorganic molecules, polyoxometalates
(POMs), primarily made up of metals (molybdenum and tungsten) and
oxygen. They are the most powerful CK2 inhibitors yet discovered,
working at very low (nanomolar) concentrations. In addition, the
researchers showed that the mode of action of POMs, although not yet
fully understood, is completely new. Unlike organic inhibitors, POMs do
not bind to the active site of the enzyme.
This work opens up several areas for further research: clarifying the
mechanism of action of these new molecules, finding the minimum
molecular entity that can inhibit enzyme activity, and finally, given
its importance in the health field, improving knowledge of how the
enzyme CK2 works. In the longer term, these results could pave the way
for new approaches to developing anti-cancer drugs.
(1) Polyoxometalates are anionic inorganic metal oxide structures that
have valuable catalytic properties.
(2) Phosphorylation enzymes called protein kinases can attach a
phosphate group to proteins that may be inactive enzymes. The addition
of the phosphate group can activate these "silent" enzymes. Protein
kinases thus play a central role in controlling the activity of numerous
enzymes in the cell.
(3)The active site of an enzyme is a particular region where the
substrates bind together and enzymatic reactions takes place.

Julien Guillaume | alfa
Further information:
http://www.cnrs-dir.fr

Further reports about: CK2 Cancer Inhibitors Kinase enzyme

More articles from Life Sciences:

nachricht Cnidarians remotely control bacteria
21.09.2017 | Christian-Albrechts-Universität zu Kiel

nachricht Immune cells may heal bleeding brain after strokes
21.09.2017 | NIH/National Institute of Neurological Disorders and Stroke

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Highly precise wiring in the Cerebral Cortex

Our brains house extremely complex neuronal circuits, whose detailed structures are still largely unknown. This is especially true for the so-called cerebral cortex of mammals, where among other things vision, thoughts or spatial orientation are being computed. Here the rules by which nerve cells are connected to each other are only partly understood. A team of scientists around Moritz Helmstaedter at the Frankfiurt Max Planck Institute for Brain Research and Helene Schmidt (Humboldt University in Berlin) have now discovered a surprisingly precise nerve cell connectivity pattern in the part of the cerebral cortex that is responsible for orienting the individual animal or human in space.

The researchers report online in Nature (Schmidt et al., 2017. Axonal synapse sorting in medial entorhinal cortex, DOI: 10.1038/nature24005) that synapses in...

Im Focus: Tiny lasers from a gallery of whispers

New technique promises tunable laser devices

Whispering gallery mode (WGM) resonators are used to make tiny micro-lasers, sensors, switches, routers and other devices. These tiny structures rely on a...

Im Focus: Ultrafast snapshots of relaxing electrons in solids

Using ultrafast flashes of laser and x-ray radiation, scientists at the Max Planck Institute of Quantum Optics (Garching, Germany) took snapshots of the briefest electron motion inside a solid material to date. The electron motion lasted only 750 billionths of the billionth of a second before it fainted, setting a new record of human capability to capture ultrafast processes inside solids!

When x-rays shine onto solid materials or large molecules, an electron is pushed away from its original place near the nucleus of the atom, leaving a hole...

Im Focus: Quantum Sensors Decipher Magnetic Ordering in a New Semiconducting Material

For the first time, physicists have successfully imaged spiral magnetic ordering in a multiferroic material. These materials are considered highly promising candidates for future data storage media. The researchers were able to prove their findings using unique quantum sensors that were developed at Basel University and that can analyze electromagnetic fields on the nanometer scale. The results – obtained by scientists from the University of Basel’s Department of Physics, the Swiss Nanoscience Institute, the University of Montpellier and several laboratories from University Paris-Saclay – were recently published in the journal Nature.

Multiferroics are materials that simultaneously react to electric and magnetic fields. These two properties are rarely found together, and their combined...

Im Focus: Fast, convenient & standardized: New lab innovation for automated tissue engineering & drug

MBM ScienceBridge GmbH successfully negotiated a license agreement between University Medical Center Göttingen (UMG) and the biotech company Tissue Systems Holding GmbH about commercial use of a multi-well tissue plate for automated and reliable tissue engineering & drug testing.

MBM ScienceBridge GmbH successfully negotiated a license agreement between University Medical Center Göttingen (UMG) and the biotech company Tissue Systems...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

“Lasers in Composites Symposium” in Aachen – from Science to Application

19.09.2017 | Event News

I-ESA 2018 – Call for Papers

12.09.2017 | Event News

EMBO at Basel Life, a new conference on current and emerging life science research

06.09.2017 | Event News

 
Latest News

Comet or asteroid? Hubble discovers that a unique object is a binary

21.09.2017 | Physics and Astronomy

Cnidarians remotely control bacteria

21.09.2017 | Life Sciences

Monitoring the heart's mitochondria to predict cardiac arrest?

21.09.2017 | Health and Medicine

VideoLinks
B2B-VideoLinks
More VideoLinks >>>